What are the key challenges in drug interaction studies for elderly patients?

The challenges include physiological variability, comorbidities that complicate treatment regimens, and the need for careful ethical considerations in clinical trials.

How can drug interaction studies improve the quality of care for seniors?

By identifying harmful drug interactions, care providers can tailor medication plans, thereby enhancing patient safety and therapeutic outcomes.

What role does consulting with a CRO play in these studies?

A Contract Research Organization (CRO) like InfinixBio provides expertise in conducting drug interaction assessments, enabling efficient and compliant study management, from design to execution.